Sold and Supplied by Healthylife Pharmacy
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
Medicare CardNo MedicareConcession
$18.95
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
Atm Strattera 60mg (Strattera) 5 tabletsStrattera is used to treat attention deficit hyperactivity disorder (ADHD) which affects up to 8 million people a day. It can be used alone or in combination with other treatments. Strattera is an selective norepinephrine reuptake inhibitor (SNRI) medicine. It works by increasing the levels of norepinephrine in the brain, helping to improve focus and reduce hyperactivity in the brain. Strattera is also often prescribed for the treatment of narcolepsy, a severe sleep disorder that can cause difficulty falling or staying asleep. Strattera can also be used to treat ADHD as a part of the treatment for narcolepsy. Strattera is also used to treat conditions that include hyperactivity, attention deficit hyperactivity disorder (ADHD) and the symptoms of mixed personality disorder (MPD). Strattera 60mg is also sometimes used in combination with other treatments to treat insomnia and anxiety.
Strattera belongs to a class of drugs called norepinephrine reuptake inhibitors (NIRIs). NIRIs work by increasing the levels of a neurotransmitter called norepinephrine, which helps to regulate nerve activity and mood. This then leads to sleep and focus.
NIRIs are a different type of drug than Strattera because they both act as SNRIs. They both work in the same way, by increasing levels of norepinephrine and the levels of dopamine in the brain. Dopamine is a brain chemical that regulates mood, energy, motivation, attention, focus, and other functions.
The exact mechanism of action of Strattera is not known. However, it is thought to occur in the brain after it is released by a nerve. This is why it is often used as a part of treatment for ADHD and narcolepsy.
This medication is usually taken once a day. The recommended dose is around 60mg taken once a day. Your doctor may adjust the dose based on your response. Do not exceed the recommended dose or take the drug for as long as prescribed by your doctor.
Your doctor may adjust the dose depending on how you respond to the drug. Do not take more or less than your prescribed dose. If you miss a dose, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take two doses at once.
Follow the directions and usage of the instructions provided for you carefully. Do not take this medication more than in a 24-hour period.
If you do not understand the instructions, consult your doctor or pharmacist.
Healthylife treats only right-sized amounts of medication. While most prescription medicine is safe to use, there are some rare cases of medication errors, which can result in severe harm to your health. If you have any concerns or questions about this medication, do not hesitate to contact your doctor.
Healthylife does not recommend that you use this drug more often than directed. If you are under 18 years of age, only take the drug if the benefits outweigh the risks. If you are over 75 years of age, only take the drug if the risks outweigh the benefits.
is a medication used to treat adults, adolescents, and children with attention deficit hyperactivity disorder (ADHD). It’s also known as the “” in recognition that this medication may be a struggle for some individuals with this condition.
In the United States, Strattera is known as a top-down medication that’s used to treat ADHD. It’s known for it’s effectiveness in managing ADHD symptoms but it also makes it convenient for spontaneous engagements with family and friends. In other words, you don’t have to drive to New York andnesia stress strike you if you’ve ever used an ADT before.
There are several possible side effects that you should be aware of before you begin taking Strattera. And you should not use Strattera if you:
Strattera belongs to a class of medications called non-selective seratonin reuptake inhibitors (NSSIs). It works by increasing levels of norepinephrine, a hormone in your brain that helps improve focus and attention.
It works that way because NSSIs are part of the reuptake process of the neurotransmitter norepinephrine. This is what leads to norepinephrine increasing in your brain. Norepinephrine is a chemical that helps you focus, stay focused, and keep quiet when you have a seizure.
Strattera, also known as atomoxetine, is a selective norepinephrine reuptake inhibitor in clinical research. It is sometimes known as a second-line treatment for Attention Deficit Hyperactivity Disorder (ADHD), although it has been approved for other indications as well.
The market is analyzed in terms of both product and service segments, with a focus on product brands. The top-5# brand name (Ademl Pharma, Takeda Pharmaceuticals, H&a Pharmaceuticals, Inerva Pharma, etc.) is the main category, with adult ADHD prevalence increasing with age.[1]
In the service segment, the product brands of Ademl Pharma are the most prominent, with adult ADHD prevalence rising with age with a 7.2% rise in that prevalence in the United States, according to IMS data. In the United Kingdom, ADHD prevalence rose 6.3% with a 15.5% rise in that prevalence in 2002. These growth factors are significant factors for Ademl Pharma’s position in the market.[2]
The product segmentation is highly influenced by the main product brands, which are Ademl Pharma and Takeda. The Ademl Pharma brands tend to have stronger product brands, such as Eli Lilly’s Strattera, whereas Takeda brands tend to have stronger brands such as AstraZeneca’s Advaira, while H&a Pharmaceuticals’ Elavil and Actonel’s Raloxifene are more established brand brands.[3]
The service segment, on the other hand, focuses on the retail and online platforms. Retail brands tend to be stronger, such as Johnson & Johnson’s Flovent or CVS Pharmacy’s CVS Cialis, while online brands are often stronger, such as Amazon’s Prime Video or Target’s Tricare, while prescription brands are less prominent.[4]
The market is analyzed across regions, such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The North American market is currently valued at approximately $20.8B in the United States, with Europe valued at approximately $11.4B.[5]
The region analyzed in this area is North America, where Ademl Pharma is the major product brand, followed by Europe, where H&a Pharmaceuticals is the most prominent, followed by Latin America, where Ademl Pharma is the most prominent, and the Middle East and Africa, where Ademl Pharma is the most prominent.[6]
The region’s insights provide insights into the market’s specific regions, such as North America, Europe, Asia Pacific, and Latin America. The North American market includes the United States, where Ademl Pharma is the most prominent, followed by the United Kingdom, where Ademl Pharma is the most prominent, and the Middle East and Africa, which include Asia Pacific, Latin America, and the Asia Pacific Region.[7-9]
The North America market is analyzed based on the U. S., Canada, Australia, New Zealand, Europe, and South Africa. The Middle East and Africa are analyzed based on the Middle East and South Africa. Asia Pacific is analyzed based on the Asia Pacific region.[10]
The drug and plant segment is analyzed in this area. The Asia Pacific region includes India, China, Japan, South Korea, and Malaysia. India is a significant growth driver, with an annual growth rate of 6.4%.[11]
The global market for ADHD drugs and plants is experiencing substantial growth. The rise of prescription drugs and the expansion of online pharmaceutical companies are contributing factors to the growing market, with the Asia Pacific region expected to see the highest growth rate in the next few years. This growth could be attributed to the rising incidence of ADHD, coupled with growing awareness and awareness of treatment efficacy.
Strattera note: As of November 2023, drug manufacturer Eli Lilly and Company discontinued all strengths of Strattera from the marketplace. Strattera generic, atomoxetine, is available.
Strattera (Generic Name: atomoxetine) is an alternative to the stimulant ADHD medications most commonly used to treat symptoms of attention deficit hyperactivity disorder () in children ages 6-12, adolescents, and adults. It is a selective norepinephrine reuptake inhibitor (SNRI) medicine.
Strattera is a non-stimulant; it is not considered a controlled substance by the Drug Enforcement Agency (DEA). It has not been studied in children under the age of 6.
Strattera was the first non-stimulant medication approved for ADHD treatment in the United States by the Food and Drug Administration () in 2002. It was also the first non-stimulant medication to be approved for treating adults with ADHD.
Strattera and are both medications used to treat ADHD, but they are fundamentally different. Adderall is a stimulant, and Strattera is a non-stimulant medication.
Strattera is the brand name for the drug atomoxetine, which is a norepinephrine reuptake inhibitor that allows the neurotransmitter norepinephrine to be available to the brain’s neurons for longer.
Adderall is the brand name for the combination of the drugs dextroamphetamine and amphetamine, and it acts on the central nervous system by boosting the number of dopamine and norepinephrine transmitters in the brain.
Generally speaking, stimulant medications are significantly more effective than non-stimulants like Strattera for treating ADHD. Stimulant medications like Adderall are considered first-line medication for treating ADHD, while non-stimulant medications, like Strattera, are considered second-line medications for treating ADHD.
Strattera is used, however, in special circumstances and patient populations:
According to information provided by the drug’s manufacturers, it can take four to eight weeks for Strattera to reach the maximum therapeutic effect. The medication lasts 24 hours. In contrast, the effects of Adderall may be felt as soon as 30 minutes to one hour. The medication lasts for four hours (Adderall) and 12 hours (Adderall XR).
According to statistics provided by the drug’s product descriptions, the most common prescriptions for Strattera are prescribed in the following groups:
The most common side effects of any kind of medication are:
Adderall is also known as a headache medication for its side effects. Patients who have experienced headache since members of their first relationship relationship have used Adderall can use when a headache has not been due to a direct physical source.
According to information provided by the drug’s manufacturers, it can take four to 8 weeks for Strattera to to work. The medication is considered to be risky with people who have experienced either active or recent uncontrolled drug and alcohol abuse, and Stratter works in the body it did not naturally use to use the medication.
Stade de France Pharmacy